| ²é¿´: 877 | »Ø¸´: 2 | |||
¿µÁú»¯³ÉÄþ²¨Ð³æ (СÓÐÃûÆø)
|
[½»Á÷]
¿µÁú»¯³ÉÉϺ£&Äþ²¨ÕÐÆ¸ÓлúºÏ³ÉÈ˲ţ¬ÆÚ´ýÄúµÄ¼ÓÈë~
|
|
¶ÔÓлúºÏ³É¸Úλ¸ÐÐËȤµÄÅóÓÑ£¬¿´¹ýÀ´~¿µÁú»¯³ÉÉϺ£ºÍÄþ²¨Ä¿Ç°¼±ÐèÒ»ÅúÓлúºÏ³É·½ÃæµÄÈ˲ţ¬Ó¦Íù½ì±¾Ë¶²©½Ô¿É~»¶ÓÓÐÐËȤµÄÅóÓÑͶµÝ¼òÀú~ Pharmaron is a premier R&D service provider for the pharmaceutical industry. Founded in 2003, Pharmaron has invested in our people and our facilities enabling us to provide high quality R&D service across a number of disciplines including chemistry, biology, DMPK, pharmacology, toxicology and chemical development. Pharmaron® has grown steadily to meet the needs of our customers. With nearly 4,000 employees and operations in China and the U.S., Pharmaron® delivers superior scientific services while maintaining close communication with our customers. Our current clients include small and large pharmaceutical companies in North America, Europe and Japan. Welcome to our web site to know more about us www.pharmaron.com Welcome to pay attention to our recruiting information on 51job and Zhaopin. You can also introduce Pharmaron to your friends. Just Join us! ÓлúºÏ³ÉÖúÀíÑо¿Ô± ¸ÚλְÔ𣺠1.¸ù¾Ý×鳤»òÖ÷¹ÜµÄ¿ÎÌâ°²ÅÅ£¬ºÏÀíÉè¼ÆÊµÑé²¢×Ðϸʵʩ£» 2.ÅäºÏ×鳤£¬¶ÀÁ¢¿ªÕ¹Ò»¶¨ÄѶȵÄȫпÎÌâ»òÖØ¸´Ò»Ð©¸ßÄѶȵĿÎÌ⣬Á¦Õù¼°Ê±µØÍê³É¿ÎÌâÈÎÎñ£» 3.ϸÐĹ۲ìʵÑ飬¹æ·¶²Ù×÷£¬µÃµ½ºÏÀíµÄʵÑé½á¹û£» 4.¿ÆÑ§·ÖÎöʵÑéÖгöÏÖµÄÎÊÌ⣬Ìá³öºÏÀíµÄ¸Ä½ø½¨Ò飬»òµÃ³öºÏÀíµÄ½áÂÛ£» 5.¼°Ê±µØÊéдE-Note¡¢ÈÕ±¨ºÍ½áÌⱨ¸æ£» 6.¸ù¾Ý¹«Ë¾ÒªÇ󣬼°Ê±µØ×ܽṤ×÷£¬ÉϽ»ÊµÑéÊý¾Ý×ÊÁÏ¡£ ÈÎÖ°×ʸñ£º 1.»¯Ñ§Ïà¹Ø×¨ÒµÑ§Ê¿»ò¾ßÓÐѧʿµÄͬµÈÀíÂÛ¼°ÊµÑéˮƽ£¬1-2ÄêʵÑéÊÒʵ²Ù¾Ñ飻 2.ÊìÁ·ÕÆÎÕÓлúºÏ³É¡¢²úÎï·ÖÀëÓë½á¹¹¼ø¶¨¼¼ÄÜ£» 3.ÊìÁ·ÕÆÎÕÎÄÏ×¼ìË÷ÊֶΣ¬¾ß±¸ÓÅÁ¼µÄÓ¢ÎĶÁдÄÜÁ¦£» 4.Á¼ºÃµÄ¾´Òµ¾«Éñ£¬Ç¿ÁÒµÄÔðÈÎÐÄ£¬¹¤×÷ÑϽ÷̤ʵ¡¢×ÐϸÈÏÕæ¡£ ÓлúºÏ³ÉÑо¿Ô± ְλÃèÊö£º 1¡¢¸ù¾Ý×鳤»òÖ÷¹ÜµÄ¿ÎÌâ°²ÅÅ£¬ºÏÀíÉè¼ÆÊµÑé²¢×Ðϸʵʩ£» 2¡¢¶ÀÁ¢³Ðµ£ÖеÈÄѶȿÎÌâÈÎÎñ£¬±£Ö¤°´Ê±Íê³É¿ÎÌâÈÎÎñ£» 3¡¢Ï¸ÐĹ۲ìʵÑ飬¹æ·¶²Ù×÷£¬µÃµ½ºÏÀíµÄʵÑé½á¹û£» 4¡¢¿ÆÑ§·ÖÎöʵÑéÖгöÏÖµÄÎÊÌ⣬Ìá³öºÏÀíµÄ¸Ä½ø½¨Ò飬»òµÃ³öºÏÀíµÄ½áÂÛ£» 5¡¢¼°Ê±µØÊéдӢÎÄE-Note¡¢ÈÕ±¨ºÍ½áÌⱨ¸æ£» 6¡¢¸ù¾Ý¹«Ë¾ÒªÇ󣬼°Ê±µØ×ܽṤ×÷£¬ÉϽ»ÊµÑéÊý¾Ý×ÊÁÏ£» 7¡¢ÅäºÏÆäËû²¿ÃÅÍê³ÉÆäËûÏà¹ØµÄ¹¤×÷¡£ ÈÎÖ°×ʸñ£º 1¡¢ÓлúºÏ³É»òÒ©ÎﻯѧÏà¹Ø×¨ÒµË¶Ê¿»ò¾ßÓÐ˶ʿͬµÈÀíÂÛ¼°ÊµÑéˮƽ£¬¿É½ÓÊÜÓ¦½ìÉú£» 2¡¢·á¸»µÄÓлúºÏ³É¾Ñ飬ÊìÁ·ÕÆÎÕÓлúºÏ³É¡¢²úÎï·ÖÀëÓë½á¹¹¼ø¶¨¼¼ÄÜ£» 3¡¢ÊìÁ·ÕÆÎÕÎÄÏ×¼ìË÷ÊֶΣ¬¾ß±¸ÓÅÐãµÄÓ¢ÎĶÁдÄÜÁ¦£» 4¡¢ÔðÈÎÐÄÇ¿£¬¾ßÓÐÁ¼ºÃµÄÍŶӺÏ×÷¾«ÉñÓ빵ͨÄÜÁ¦¡£ ¸ß¼¶ÓлúºÏ³ÉÑо¿Ô± ¸ÚλְÔ𣺠1¡¢¸ù¾ÝÏîÄ¿¾Àí»ò¸±×ܵĿÎÌâ°²ÅÅ£¬ºÏÀíÉè¼ÆÊµÑé·½°¸²¢×Ðϸʵʩ£» 2¡¢¶ÀÁ¢³Ðµ£¸ßÄѶȿÎÌâÈÎÎñ£¬±£Ö¤°´Ê±Íê³É¿ÎÌâÈÎÎñ£» 3¡¢¿ÆÑ§·ÖÎöʵÑéÖгöÏÖµÄÎÊÌ⣬Ìá³öºÏÀíµÄ¸Ä½ø½¨Ò飬»òµÃ³öºÏÀíµÄ½áÂÛ£» 4¡¢ÅäºÏÏîÄ¿¾Àí»ò¸±×ܶ¨ÆÚÏòÅ·ÃÀ¿Í»§¶¨»ã±¨¿ÎÌâ½øÕ¹Çé¿ö£» 5¡¢¼°Ê±µØÊéдӢÎÄE-Note¡¢ÈÕ±¨ºÍ½áÌⱨ¸æ£» 6¡¢¸ù¾Ý¹«Ë¾ÒªÇ󣬼°Ê±µØ×ܽṤ×÷£¬ÉϽ»ÊµÑéÊý¾Ý×ÊÁÏ£» ÈÎÖ°×ʸñ£º 1¡¢Óлú»¯Ñ§»òÒ©ÎﻯѧÏà¹Ø×¨Òµ²©Ê¿Ñ§Àú£¬Ñо¿·½ÏòΪÓлúºÏ³É£¬Ò©ÎﻯѧºÏ³É£¬ÌÇ»¯Ñ§¡¢ºËÜÕ£¬ÌÇÖ¬ÀàºÏ³ÉµÈ£» 2¡¢·á¸»µÄÓлúºÏ³É¾ÑéºÍ½ÏÇ¿µÄ¿ÆÑй¥¹ØÄÜÁ¦£¬¾ß±¸ºÏ³ÉÏß·Éè¼ÆÄÜÁ¦£» 3¡¢½ÏÇ¿¿¹Ñ¹Á¦£¬ÔðÈÎÐÄÇ¿£¬¾ß±¸ÍŶӺÏ×÷¾«Éñ£¬¿É´øÁìÒ»ÖÁ¶àÃûʵÑéÖúÀí¿ªÕ¹Ñо¿¹¤×÷£» 4¡¢ÓÅÐãµÄÓ¢ÓïÌý˵¶ÁдÄÜÁ¦¡£ ÌØ±ðÌáʾ£º 1¡¢¹¤×÷µØµãΪ¿µÁú»¯³ÉÉϺ£ºÍÄþ²¨·Ö¹«Ë¾£¨Äþ²¨º¼ÖÝÍåÐÂÇø£©£¬¸£Àû´ýÓö·áºñ£» 2¡¢EmailÖ÷ÌâÇë°´ÏÂÁиñʽ£ºÐÕÃû+ӦƸְλ+ѧÀú+¹¤×÷¾Ñé¡£·¢ËÍÖÁjie.huang@pharmaron-bj.com£» 3¡¢Ç뽫¼òÀúÓëÑо¿¹¤×÷±¨¸æÒ»²¢Í¶µÝ¡£ |
» ²ÂÄãϲ»¶
Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
272Çóµ÷¼Á
ÒѾÓÐ7È˻ظ´
352·Ö »¯¹¤Óë²ÄÁÏ
ÒѾÓÐ3È˻ظ´
0703»¯Ñ§
ÒѾÓÐ6È˻ظ´
Ò»Ö¾Ô¸Äϲý´óѧ324Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
Çóµ÷¼Á
ÒѾÓÐ3È˻ظ´
266·ÖÇó²ÄÁÏ»¯¹¤Ò±½ð¿óÒµµÈרҵµÄµ÷¼Á
ÒѾÓÐ4È˻ظ´
Ò»Ö¾Ô¸ÄÏʦ´ó0703»¯Ñ§ 275Çóµ÷¼Á
ÒѾÓÐ4È˻ظ´
085701»·¾³¹¤³ÌÇóµ÷¼Á
ÒѾÓÐ3È˻ظ´
266Çóµ÷¼Á
ÒѾÓÐ10È˻ظ´

cz0808
гæ (ÖøÃûдÊÖ)
- Ó¦Öú: 26 (СѧÉú)
- ½ð±Ò: 3924.6
- É¢½ð: 3927
- ºì»¨: 8
- ɳ·¢: 2
- Ìû×Ó: 2083
- ÔÚÏß: 213Сʱ
- ³æºÅ: 3136194
- ×¢²á: 2014-04-14
- רҵ: ÓлúºÏ³É
2Â¥2017-02-24 15:00:35
¿µÁú»¯³ÉÄþ²¨
гæ (СÓÐÃûÆø)
- Ó¦Öú: 0 (Ó×¶ùÔ°)
- ½ð±Ò: 12.7
- É¢½ð: 66
- ºì»¨: 1
- Ìû×Ó: 108
- ÔÚÏß: 12.7Сʱ
- ³æºÅ: 3793892
- ×¢²á: 2015-04-07
- רҵ: ÓлúºÏ³É

3Â¥2017-02-26 13:56:16














»Ø¸´´ËÂ¥